5-Iodo-2-aminoindane (5-IAI) is a drug which acts as a releasing agent of serotonin norepinephrine and dopamine. It was developed in the 1990s by a team led by David E. Nichols at Purdue University. 5-IAI fully substitutes for MDMA in rodents and is a putative entactogen in humans.
This page contains content from the copyrighted Wikipedia article "5-IAI"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
